Create a Report
Please provide report title
Please provide location
Please provide details
Get alerts and updates for your case! Your contact information is not shown on the website.
This information is not shown on the website. We can notify you of updates, and may contact you for more information to help resolve or follow up on your issue.
Please provide email or phone
Please provide email or phone

We do not show your email or contact info

Please accept our Terms & Conditions
Add photos or video
We recommend photos and videos to help explain your report
Use camera
Select from library
Email or SMS copy of report
Enter below to get emailed a copy of your report, or sms a link to your report
Please provide email or phone
Please provide email or phone
Please accept our Terms & Conditions
Thank you for your report!
IMPORTANT - YOUR REPORT IS QUEUED - IT MAY TAKE UP TO 12 HOURS FOR YOUR REPORT TO SHOW ON OUR HOME PAGE (IF NOT OPTED AS PRIVATE)
Visit our learn pages for more helpful information or, email us: support@safelyhq.com
Goodbye! and best wishes in your recovery
Please provide location
Please provide location
Please provide report title
Please provide details
Please accept our Terms & Conditions
Get alerts and updates for your case! Your contact information is not shown on the website.

This information is not shown on the website. We can notify you of updates, and may contact you for more information to help resolve or follow up on your issue.

or
Please provide email or phone
Thank you for your report!

IMPORTANT - YOUR REPORT IS QUEUED - IT MAY TAKE UP TO 12 HOURS FOR YOUR REPORT TO SHOW ON OUR HOME PAGE (IF NOT OPTED AS PRIVATE)

If your report is poison related call 1-800-222-1222 for a free consultation with a live medical poisoning expert

Visit our learn pages for more helpful information or, email us: support@safelyhq.com

Goodbye! and best wishes in your recovery

Family Dollar, 2610 W 71st St, Chicago, IL, USA

Total all time reports:  1
Latest report: April 17, 2020 11:00 AM
Family Dollar Store #6944, 2610 W 71st St, Chicago, Il, USA, Family Dollar, 2610 W 71st St, Chicago, IL, USA

Family Dollar Store #6944, 2610 W 71st St, Chicago, Il, USA

April 17, 2020 11:00 AM

“Report date: Apr 14, 2020
5. Procedures for responding to vomiting and diarrheal events
- comments: no procedure in place for responding to vomiting and diarrheal events. Instd to provide procedure and supplies effective against norovirus. Priority foundation 7-38-005.

36. Thermometers prov ... See Moreided & accurate
- comments: no food temperature measuring device. Instd to provide and maintain same.

38. Insects, rodents, & animals not present
- comments: over 100 mice droppings scattered on floor in rear storage room and underneath display shelves. Excessive clutter in rear storage area and stock on floor. Instd to remove all droppings, clean and sanitize affected areas, elevate stock and remove clutter to prevent harborage. Priority foundation 7-38-020(a).

Source: chicago.gov
See Less
Reported By SafelyHQ.com User

Related Reports

June 28, 2020 11:29 PM

“I purchase an ice cream cake and took it straight to the gathering for Father's Day. Opened it up and ... See Morethere was a dead roach on the side of the cake where the cake and card board meet!!' I was so creeped out and disgusted let alone embarrassed. I paid thirty something dollars for this cake. When I took it back the guy just look in the box and said you'll get your money back in 7 to 10 days. He didn't apologize or anything. I should have known not to in there because the store itself is disgusting. The glass doors are filthy. There are napkins and bags just garbage all around this place of business. This just was so disgustin. Too be honest I don't even know who they are still open.
So unsanitary
See Less
Reported By SafelyHQ.com User

June 28, 2020 12:00 PM

“An employee at Longman & Eagle tested positive for Covid-19.

Source: blockclubchicago.org See Less
Reported By SafelyHQ.com User

June 9, 2020 12:00 PM

“Two more employees at Circuit Court of Cook County have tested positive for COVID-19.

Source: chronicleillinois.com See Less
Reported By SafelyHQ.com User

Another employee contracts COVID -19, Circuit Court of Cook County, 555 W Harrison St, Chicago, IL 60607, USA

Circuit Court of Cook County, 555 W Harrison St, Chicago, IL 60607, USA

June 4, 2020 12:00 PM

“The 26th employee at Cook County Circuit Court Clerk's office has contracts COVID -19

Source: chicago.suntimes.com See Less
Reported By SafelyHQ.com User

June 2, 2020 12:00 PM

“Mayor Lori Lightfoot (D) announced on May 31 that a curfew would be imposed from 9 p.m. to 6 a.m. until further notice. Source: thehill.com See Less
Reported By SafelyHQ.com User

May 19, 2020 12:00 PM

“At least one Ford assembly plant employee at the South Side facility on South Torrence Avenue has tested positive for COVID-19

Source: wgntv.com See Less
Reported By SafelyHQ.com User

May 12, 2020 12:00 PM

“Both my parents got results back positive for COVID-19 and I’m a bit overwhelmed bc they have been cautious and still ended up sick. So, far the symptoms are minor. But, I’m trying so hard not to panic bc I don’t want to think about losing either of them. See Less
Reported By SafelyHQ.com User

Warehouse worker tests positive for COVID -19., Amazon Delivery Station - (Chicago-McKinley Park) DCH1, 2801 S Western Ave, Chicago, IL 60608, USA

Amazon Delivery Station - (Chicago-McKinley Park) DCH1, 2801 S Western Ave, Chicago, IL 60608, USA

May 7, 2020 12:00 PM

“An Amazon employee at the Little Village warehouse has tested positive for COVID-19

Source: chicago.suntimes.com See Less
Reported By SafelyHQ.com User

May 3, 2020 12:00 PM

“Five workers at Whole Foods have tested positive for COVID-19 since April 9th. The latest two cases of coronavirus were announced Friday May 1st. If you visited the grocery store during that time, please report it and any other location that you visited.

Source: chicago.cbslocal.com See Less
Reported By SafelyHQ.com User

May 3, 2020 12:00 PM

“Hey, everyone. This is a surprising thing to have happened, but I tested positive for COVID-19. My symptoms were just a short-lived sore throat, the sniffles & a loss of taste/smell. The good news about my COVID-19 experience is that it’s so mild, but the bad news is that I may have given it to peop ... See Morele without realizing I was sick. I was taking every precaution and lived alone (roommate had quarantined with her bf), but I still managed to catch it.
My experience is testament to a few things. One, not every COVID case is life-threatening. That’s good! But two, it’s so, so contagious that, even with a face mask and social distancing, I managed to get sick.
Anyway, thank you so much to Swedish Covenant Hospital for running the drive-thru clinic that helped me get tested. I’d been screened out by my doctor and wasn’t able to get a test that way.
See Less
Reported By SafelyHQ.com User

Recent Interesting Reports

June 5, 2020 5:00 PM

“Company name: Marksans Pharma Limited, India
Brand name: Time-Cap Labs, Inc.
Product recalled: Metformin Hydrochloride Extended-Release Tablets, USP 500mg
Reason of the recall: Due to detection of N-Nitrosodimethylamine (NDMA)
FDA Recall date: June 05, 2020
Recall details: Marksans Pharma Limi ... See Moreted, India is voluntarily recalling Metformin Hydrochloride Extended-Release Tablets, USP 500mg, lot # XP9004, to the consumer level. FDA analysis has found the product to contain N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Daily Intake Limit (ADI) of 96ng/day. Risk Statement: NDMA is classified as a probable human carcinogen (a substance that could cause cancer) based on results from laboratory tests. NDMA is a known environmental contaminant found in water and foods, including meats, dairy products and vegetables.

Marksans Pharma Limited has not received any reports of adverse events related to this recall to date. Metformin Hydrochloride Extended-Release Tablets, USP 500mg is indicated as an adjunct to diet and exercise to improve blood glucose control in adults with type 2 diabetes mellitus and is packaged in 100 count bottles with NDC code 49483-623-01. The affected Metformin Hydrochloride Extended-Release Tablets, USP 500mg, are white to off white, capsule shaped, biconvex tablets, debossed with ‘101’ on one side and plain on the other side.

Product name: Metformin Hydrochloride Extended Release Tablets USP, 500 mg
Lot #: XP9004
Expiry Date (MM/YYYY): 12/2020

The product can be identified by lot # XP9004 and expiration date 12/2020. Metformin Hydrochloride Extended-Release Tablets, USP 500mg, lot # XP9004 was distributed by Time-Cap Labs, Inc. nationwide in the USA to wholesalers who further distributed to pharmacies. Marksans Pharma Limited is notifying its distributors and customers by issuing notification letter and press release and is arranging for return/replacement etc. of recalled product lot.

Distributors/retailers that have Metformin Hydrochloride Extended-Release Tablets, USP 500mg, lot # XP9004 which is being recalled should return to place of purchase. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product. Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax. Complete and submit the report Online

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.
Check the full recall details on fda.gov

Source: FDA
See Less
Reported By SafelyHQ.com User

May 26, 2020 9:34 AM

“How could u serviced me raw wings to my family drying the cov 19 crises. I try go back talk to person who works there and her answer was, they are fine really disgusted by their food. how could you serve ... See Moreme and my family raw chicken wings! :( very upset See Less
Reported By SafelyHQ.com User

May 27, 2020 9:34 AM

“No chips with my meal and pink chicken Face with symbols over mouth Absolutely grim man See Less
Reported By SafelyHQ.com User

June 22, 2020 11:34 AM

“Thanks for serving my cousin some raw chicken meat! One bite of raw ... See Moreelyhq.com/product/chicken#scroll" title="Product: Chicken">chicken meat wont hurt right? See Less
Reported By SafelyHQ.com User

June 11, 2020 1:00 PM

“Company name: Lupin Pharmaceuticals, Inc
Brand name: Lupin
Product recalled: Metformin Hydrochloride Extended-release Tablets
Reason of the recall: Detection of N-Nitrosodimethylamine (NDMA)
FDA Recall date: June 11, 2020
Recall details: Lupin Pharmaceuticals Inc. is voluntarily recalling Met ... See Moreformin Hydrochloride Extended-Release Tablets USP (generic equivalent of Fortamet®), 500mg, lot G901203 to the consumer level. FDA analysis revealed that this lot exceeded the Acceptable Daily Intake Limit for the impurity N-Nitrosodimethylamine (NDMA). To date, Lupin Pharmaceuticals Inc. has not received any reports of adverse events related to this recall.

Risk Statement: NDMA is classified as a probable human carcinogen (a substance that could cause cancer) based on results from laboratory tests. NDMA is a known environmental contaminant and found in water and foods, including meats, dairy products and vegetables. Metformin Hydrochloride Extended-Release Tablets USP, 500mg is a prescription oral medication indicated as an adjunct to diet and exercise to improve blood glucose control in adults with type 2 diabetes mellitus. It is packaged in a bottle containing 60 tablets with NDC 68180-336-07. The affected lot of Metformin Hydrochloride Extended-Release Tablets USP, 500mg is included in below table:

- Product Name: Metformin Hydrochloride Extended-Release Tablets USP, 500mg

- NDC: 68180-336-07

- Lot Number: G901203

- Expiration Date: 12/2020

The product can be identified by the NDC and the lot number available on the side of the bottle label. Metformin Hydrochloride Extended-Release Tablets USP, 500mg was distributed nationwide in the USA to wholesalers, distributors, and mail order pharmacies.

Lupin Pharmaceuticals Inc. is notifying its wholesalers, distributors, and mail order pharmacies by phone and through recall notification and is arranging for the return of all the recalled product lot. Patients taking Metformin Hydrochloride Extended-Release Tablets, USP 500 mg, are advised to continue taking their medication and contact their pharmacist, physician, or medical provider for advice regarding an alternative treatment. According to the U.S. Food & Drug Administration, it could be dangerous for patients with this serious condition to stop taking their metformin without first talking to their health care professionals.

Check the full recall details on fda.gov

Source: FDA
See Less
Reported By SafelyHQ.com User

April 29, 2020 7:00 PM

“Company name: CME America
Brand name: CMEAmerica BodyGuard
Product recalled: Infusion pumps and infusion sets
Reason of the recall: pumps may not deliver fluid at the accuracy specified in the instructions for use and infusion sets may under-deliver fluids
FDA Recall date: April 29, 2020
Recall ... See Moredetails: CME America, a wholly owned subsidiary of BD (Becton, Dickinson and Company), a leading global medical technology company, today issued the following update regarding two previously announced voluntary recalls, one related to all models of CMEAmerica BodyGuard® infusion pumps (FDA Recall Number: Z-1474-2020) and the other related to one of the device's infusion sets (FDA Recall Number: Z-1442-2020). Both previously announced recalls have now been designated as Class I recalls by the U.S. Food and Drug Administration (FDA), which means the FDA believes that there is a reasonable probability that use of the recalled product(s) will cause serious adverse health consequences or death.

CME America previously notified customers affected by each recall and provided guidance on the potential impact to device performance when the affected products were used. Today, the company has issued an updated customer letter with additional guidance and to inform customers of the decision to suspend distribution of the BodyGuard® infusion pump system and to remove all existing products from the U.S. market.

The following is a summary of each individual product recall details:

CMEAmerica BodyGuard® Infusion Pump Recall

Details On Jan. 6, 2020, the company initiated a voluntary recall to notify customers of certain scenarios where pumps may not deliver fluid at the accuracy specified in the instructions for use that could result in a slower than expected delivery of medication (under-infusion), and/or faster than expected delivery of medication (over-infusion). Results indicate that pumps may have a delivery inaccuracy of up to ~13%. To date, no reports of patient injury has been received related to this previously announced voluntary recall. CME America has assessed the potential risks associated with the issues outlined in the initial voluntary recall and determined that the BodyGuard® infusion pump may continue to be used in certain situations in accordance with the Operator's Manual and the additional mitigations outlined in the updated customer letter until the pumps have been removed from the market.

To ensure customers retain access to critical medical equipment, particularly as the COVID-19 pandemic continues to evolve in the United States, CME America will implement a phased market removal and will continue to support the following activities in order to help limit clinical disruption and maintain patient focus during the COVID-19 pandemic: Use of products in the field in accordance with the Operator's Manual and the additional mitigations outlined in the updated customer letter; Product service and repair activities at CME America and Authorized Service Depots; and Supply of infusion sets and accessories to support the infusion pumps remaining in the field.

The BodyGuard® infusion pump is designed to deliver fluids or medications into a patient's body in controlled amounts. The pump administers fluids through an infusion tubing set into a patient's vein or through other cleared routes of administration. The system is intended for patients who require maintenance medications, PCA therapy, parenteral nutritional fluids, and general IV fluid therapy in hospital and home care environments. Typical applications for the BodyGuard® infusion pumps include but are not limited to chemotherapy, pain management, TPN, enteral nutrition fluids and antibiotics.

The recall and market removal affect approximately 28,400 devices, including all models of BodyGuard® infusion pumps listed below. These devices are primarily used in outpatient settings.
- BodyGuard 121
- BodyGuard 323
- BodyGuard 545*
- BodyGuard 575*
- BodyGuard 545 ColorVision
- BodyGuard 575 ColorVision
- CMExpress

*Note: These two pump models were inadvertently left out of the initial customer notification

CMEAmerica BodyGuard® Microset Infusion Set Recall

Details On Sept. 16, 2019, the company initiated a voluntary recall to notify customers that certain lots of BodyGuard® Microset infusion sets, when used with the BodyGuard® infusion pump, may under-deliver fluids up to 50% at the highest flow rates. At the time of the recall, CME America informed customers in the recall announcement to discard all remaining inventory of the infusion sets (Catalog #A120-003XYVA) and committed to reimbursing impacted customers. To date, no reports of patient injury has been received related to this previously announced voluntary recall. CME America immediately stopped shipments of the affected infusion sets. This FDA classification does not change the previous guidance provided in the company's September recall announcement to customers. Affected products include:

CMEAmerica BodyGuard® Microset, Catalog #A120-003XYVA.

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

Check the full recall details on fda.gov

Source: FDA
See Less
Reported By SafelyHQ.com User

July 13, 2020 11:27 AM

“Do not order from here See Less
Reported By SafelyHQ.com User

June 18, 2020 11:00 PM

“Company name: GSK Consumer Healthcare
Brand name: Robitussin
Product recalled: Cough and cold products
Reason of the recall: Incorrect dosing cups
FDA Recall date: June 18, 2020
Recall details: GSK Consumer Healthcare is voluntarily recalling to the retail level two lots (listed below) of Ch ... See Moreildren's Robitussin® Honey Cough and Chest Congestion DM and one lot of Children's Dimetapp® Cold and Cough, due to the inclusion of incorrect dosing cups. During the review of the packaging documents for these products, GSK discovered that the dosing cups for the Children's Robitussin® Honey product are missing the 5 mL and 10 mL graduations, while the dosing cups for the Children's Dimetapp® product are missing the 10 mL graduation. The dosing cups packaged with both products only have the 20 mL graduation.

There is a potential risk of accidental overdose if caregivers dispensing the syrup do not notice the discrepancies between the graduations printed on the dosing cups and the indicated amounts to be administered (as directed in the instructions for use). Children's Robitussin Honey Cough & Chest Congestion DM contains 10 mg dextromethorphan HBr USP and guaifenesin USP 100 mg per 10 mL, and is labeled for children 4 and older, as well as adults. Children's Dimetapp Cold & Cough contains 2 mg brompheniramine maleate USP, 10 mg dextromethorphan HBr USP, and 5 mg phenylephrine HCl USP per 10 mL, and is labeled for children 6 and older, as well as adults.

Symptoms of overdose of either product may include any of the following: impaired coordination; brain stimulation causing increase in energy, elevation in blood pressure, heart rate, and respiration; a lack of energy and enthusiasm; severe dizziness or drowsiness; slow heart rate; fainting; psychotic behaviour; restlessness; seizure; decreased respiration; nausea; vomiting; constipation; diarrhea; abdominal pain; visual and hearing hallucinations; urinary retention.

As of the date of the recall announcement, GSK Consumer Healthcare has not received any adverse events related to these products or consumer complaints regarding the incorrect dosing cups supplied with the product. The recall is limited to the three lots listed below:

Children's Robitussin® Honey Cough and Chest Congestion DM (4oz)
NDC 0031-8760-12
Lots: 02177 (Exp. Jan. 2022) / 02178 (Exp. Jan. 2022)

Children's Dimetapp® Cold and Cough (8oz)
NDC 0031-2234-19
Lot: CL8292 (Exp. Sep. 2021)

These lots were distributed nationwide between February 5, 2020 and June 3, 2020 within the United States. GSK Consumer Healthcare has notified wholesalers, distributors and retailers to arrange for return of any recalled product. Wholesalers, distributors and retailers with an existing inventory of the lots being recalled should stop distribution and quarantine these lots immediately.

Wholesalers, distributors and retailers that have further distributed the recalled product should notify any accounts or additional locations which may have received the recalled product from them. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this product. Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration. In December 2018, GlaxoSmithKline plc reached an agreement with Pfizer, Inc. to combine their consumer health businesses into a new Joint Venture. August 01, 2019 was the first day of the new GSK Consumer Healthcare Joint Venture. Thus, when identifying impacted product, please be aware the Pfizer company name will still be present on the label.

Check the full recall details on fda.gov

Source: FDA
See Less
Reported By SafelyHQ.com User

July 10, 2020 5:30 AM

“since no one wants to answer me when I ask about being served raw chicken I’ll just keep trying. Feel free to actually reach out See Less
Reported By SafelyHQ.com User

April 12, 2020 12:00 PM

“Details: On Friday, Jacksonville University (JU) confirmed that an Aramark employee working at Riverview Cafe on campus has tested positive for COVID-19.
The university says the individual last worked in the cafe on April 4th. The cafe will be closed to allow time for cleaning and sanitization. ... See MoreReport: 4/10/2020
Source: firstcoastnews.com
See Less
Reported By SafelyHQ.com User